Wake Forest University Health Sciences — Clinical Trial Pipeline
Wake Forest University Health Sciences has 11 registered trials in the index.
Trials (11)
- Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors Phase 1 · Wake Forest University Health Sciences
- Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer N/A · Wake Forest University Health Sciences
- Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors N/A · Wake Forest University Health Sciences
- Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases N/A · Wake Forest University Health Sciences
- Adaptation of an eHealth (Web-application) Platform for Delivery of a Sedentary Behavior Intervention Among Prostate Cancer Patients N/A · Wake Forest University Health Sciences
- B-Cell Hematologic Malignancy Vaccination Registry N/A · Wake Forest University Health Sciences
- CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma Phase 1 · Wake Forest University Health Sciences
- Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain N/A · Wake Forest University Health Sciences
- Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Phase 1 · Wake Forest University Health Sciences
- A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk Patients N/A · Wake Forest University Health Sciences
- Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy N/A · Wake Forest University Health Sciences
Related landscapes
- Brain Neoplasms, Malignant
- Brain Neoplasms, Benign
- Malignant Meningioma
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.